Hyundai Bio’s stock price is rising.
According to the Korea Exchange on the 31st, as of 2:25 pm on the same day, Hyundai Bio is trading at 29,500 won, up 800 won (2.79%) from the previous trading day.
It is interpreted that Hyundai Bio’s stock price is rising due to monkeypox.
The Korea Centers for Disease Control and Prevention (KCDC) will evaluate the risk of monkeypox, which is increasing in number of confirmed cases from around the world on the 31st, and discuss future countermeasures.
Lee Sang-won, head of the Epidemiological Investigation and Analysis Group of the Central Quarantine Countermeasures Headquarters (Bang Dae-bon) said at a briefing on the morning of the day, “Today afternoon, we will hold a crisis assessment meeting chaired by the deputy director of the Korea Centers for Disease Control and Prevention (KCDC).” At the meeting, the government plans to discuss whether monkeypox is designated as a legal infectious disease and whether to declare a crisis stage.
© ‘Global Economic Daily in 5 Languages’ Ajou Economic Daily. Unauthorized reproduction and redistribution prohibited